[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339026-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339026-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","establishment-and-characterization-of-an-epstein-barr-viruspositive-cell-line-from-a-non-keratinizing-differentiated-primary-nasopharyngeal-carcinoma","Establishment and Characterization of an Epstein-Barr Virus–positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma","","Nasopharyngeal carcinoma (NPC) is etiologically linked to Epstein-Barr virus (EBV) and is endemic in Southern China and Southeast Asia, yet representative NPC cell lines remain scarce due to EBV episome loss and compromised authenticity of existing models. A new EBV-positive NPC cell line, NPC268, is established from a primary non-keratinizing, differentiated NPC tissue. NPC268 supports productive EBV lytic reactivation and shows high tumorigenicity in immunodeficient mice. Multi-omics profiling reveals genome similarities to the originating tissue, hypomethylation, immune-pathway enrichment, and drug-screen biomarkers across 339 compounds.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/establishment-and-characterization-of-an-epstein-barr-viruspositive-cell-line-from-a-non-keratinizing-differentiated-primary-nasopharyngeal-carcinoma/339026/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/establishment-and-characterization-of-an-epstein-barr-viruspositive-cell-line-from-a-non-keratinizing-differentiated-primary-nasopharyngeal-carcinoma/339026.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are new EBV-positive NPC cell line models needed?","Question",{"text":63,"@type":64},"Representative NPC cell lines are scarce because EBV episomes often get lost during prolonged propagation, and prior models may not remain authentic. This motivates the development of new, reliable EBV-positive NPC models.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What are the key properties of the newly established NPC268 cell line?",{"text":68,"@type":64},"NPC268 is derived from a primary non-keratinizing, differentiated NPC tissue, undergoes productive lytic EBV reactivation, and is highly tumorigenic in immunodeficient mice.",{"name":70,"@type":61,"acceptedAnswer":71},"What did multi-omics and drug screening show for NPC268?",{"text":72,"@type":64},"Whole-genome sequencing showed close similarity to the tissue of origin, including large chromosomal rearrangements, while bisulfite and RNA sequencing indicated a hypomethylated genome and immune-related pathway enrichment. Drug screening with 339 compounds across multiple NPC lines revealed biomarkers linked to specific drug classes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339026,1790301396,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","RESEARCH ARTICLE  [https://doi.org/10.1158/2767-9764.CRC-23-0341](https://doi.org/10.1158/2767-9764.CRC-23-0341)   \nEstablishment and Characterization of an Epstein-Barr Virus–positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma  \nAnnie Wai Yeeng Chai1 , Shi Mun Yee1 , Hui Mei Lee1 , Norazlin Abdul Aziz2 , 3 , Pei San Yee1 , Marini Marzuki2 , Ka Wo Wong4 , Alan K.S. Chiang4 , Larry Ka-Yue Chow5 , Wei Dai5 ,  \nTeng Fei Liu6 , Lu Ping Tan2 , Alan Soo Beng Khoo2 , 7 , 8 , Kwok Wai Lo9 , Paul V. H. Lim10 , Pathmanathan Rajadurai11 , 12 , Howard Lightfoot13 , Syd Barthorpe13 , Mathew J. Garnett13 , and Sok Ching Cheong1 , 14  \nOPEN  \nACCESS  \nCheck for updates  \nABSTRACT  \nNasopharyngeal carcinoma (NPC), a cancer that is etiologically associated with the Epstein-Barr virus (EBV), is endemic in Southern China and Southeast Asia. The scarcity of representative NPC cell lines owing to the frequent loss of EBV episomes following prolonged propagation and compromised authenticity of previous models underscores the critical need for new EBV-positive NPC models. Herein, we describe the establishment of a new EBV-positive NPC cell line, designated NPC268 from a primary non-keratinizing, differentiated NPC tissue. NPC268 can undergo productive lytic reactivation of EBV and is highly tumorigenic in immunodeficient mice. Whole-genome sequencing revealed close similarities with the tissue of origin, including large chromosomal rearrangements, while whole-genome bisulfite sequencing and RNA sequencing demonstrated a hypomethylated genome and enrichment in immune-related  \npathways, respectively. Drug screening of NPC268 together with six other NPC cell lines using 339 compounds, representing the largest highthroughput drug testing in NPC, revealed biomarkers associated with specific drug classes. NPC268 represents the first and only available EBV-positive non-keratinizing differentiated NPC model, and extensive genomic, methylomic, transcriptomic, and drug response data should facilitate research in EBV and NPC, where current models are limited.  \nSignificance: NPC268 is the first and only EBV-positive cell line derived from a primary non-keratinizing, differentiated nasopharyngeal carcinoma, an understudied but important subtype in Southeast Asian countries. This model adds to the limited number of authentic EBV-positive lines globally that will facilitate mechanistic studies and drug development for NPC.  \nIntroduction  \nNasopharyngeal carcinoma (NPC) has striking geographical variations in incidence trends, and its age-standardized rate ranges from approximately 0.4 cases  \n1 Translational Cancer Biology Research Unit, Cancer Research Malaysia, Malaysia.  \n2 Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, Ministry of Health, Malaysia. 3 Faculty of Medicine, Universiti Teknologi MARA, Malaysia. 4 Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China. 5 Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China. 6 School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China. 7 Institute for Research, Development and Innovation and School of Postgraduate Studies, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia. 8 Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. 9 Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, P. R. China. 10 Tung Shin Hospital, Malaysia. 11 Subang Jaya Medical Centre, Malaysia. 12Jeffrey Cheah School of  \nper 100,000 people per year in North America and Europe to >20 cases per 100,000 people per year in Southern China (1, 2) . It is endemic to Southeast Asia and is the fifth most common cancer in Malaysia (3) . Non-keratiniz","cbCaibd2MPv7nFVe","https://ap.wps.com/l/cbCaibd2MPv7nFVe","pdf",16882392,15,"English","# Abstract\n# Significance\n# Introduction","[{\"question\":\"Why are new EBV-positive NPC cell line models needed?\",\"answer\":\"Representative NPC cell lines are scarce because EBV episomes often get lost during prolonged propagation, and prior models may not remain authentic. This motivates the development of new, reliable EBV-positive NPC models.\"},{\"question\":\"What are the key properties of the newly established NPC268 cell line?\",\"answer\":\"NPC268 is derived from a primary non-keratinizing, differentiated NPC tissue, undergoes productive lytic EBV reactivation, and is highly tumorigenic in immunodeficient mice.\"},{\"question\":\"What did multi-omics and drug screening show for NPC268?\",\"answer\":\"Whole-genome sequencing showed close similarity to the tissue of origin, including large chromosomal rearrangements, while bisulfite and RNA sequencing indicated a hypomethylated genome and immune-related pathway enrichment. Drug screening with 339 compounds across multiple NPC lines revealed biomarkers linked to specific drug classes.\"}]","Establishment and Characterization of an Epstein-Barr Virus–positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma | PDF",1790027400,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a82ad0bb4ee06244eb5b3030574872c.webp",983,1263,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6fa4d4bc171e5ec2ae81afbcc7fe007.webp",982,1262,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9439b274448c13bec8ee140dc23bd9bc.webp",981,1261,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f63e1987e34bdcd605e6b4655e79d22c.webp",980,1259]